IntriCon Names Jim Houlihan Vice President of Direct-to-Consumer Hearing Healthcare Sales, President of Hearing Help Express
July 31 2017 - 6:00AM
Business Wire
IntriCon Corporation (NASDAQ: IIN), a designer,
developer, manufacturer and distributor of miniature and
micro-miniature body-worn devices, today announced that it has
named Jim Houlihan vice president of direct-to-consumer hearing
healthcare sales and president of Hearing Help Express (HHE),
effective immediately.
Houlihan has been serving as the interim leader at HHE since
October 2016, and has more than 20 years of executive management,
business strategy development, and consumer marketing and
advertising experience—spanning both digital and traditional. Most
recently, he served as chief executive officer of EMECOLE Inc., a
chemical manufacturer and distributor. Prior to EMECOLE, he was
head of Mettler-Toledo PCE North America—a pharmaceutical
track-and-trace solutions firm. He also held other leadership
positions within the company.
Said Mark S. Gorder, IntriCon’s president and chief executive
officer, “We are pleased to welcome Jim to the IntriCon team. As we
work diligently to create and cultivate a new channel to deliver
superior, outcomes-based affordable hearing healthcare directly to
consumers, Jim’s deep experience—particularly in the digital
arena—is critical for HHE’s online evolution and long-term
success.”
Houlihan earned his bachelor’s degree in new and small business
management from Georgetown University, Washington, D.C. He also
holds a Master of Business Administration in finance, accounting
and strategy from the University of Chicago’s Booth School of
Business.
Said Houlihan, “I am excited to join IntriCon, a company with a
deep breadth of proprietary technology and a compelling future. I
look forward to working with the team to advance the company’s
vision of a value-based ecosystem of hearing healthcare that
provides affordable and accessible solutions to millions of
unserved or underserved Americans.”
About IntriCon Corporation
Headquartered in Arden Hills, Minn., IntriCon Corporation
designs, develops, manufactures and distributes miniature and
micro-miniature body-worn devices. These advanced products help
medical, healthcare and professional communications companies meet
the rising demand for smaller, more intelligent and better
connected devices. IntriCon has facilities in the United States,
Asia, the United Kingdom and Europe. The company’s common stock
trades under the symbol “IIN” on the NASDAQ Global Market. For more
information about IntriCon, visit www.intricon.com.
Forward-Looking Statements
Statements made in this release and in IntriCon’s other public
filings and releases that are not historical facts or that include
forward-looking terminology are “forward-looking statements” within
the meaning of the Securities Exchange Act of 1934, as amended.
These forward-looking statements may be affected by known and
unknown risks, uncertainties and other factors that are beyond
IntriCon’s control, and may cause IntriCon’s actual results,
performance or achievements to differ materially from the results,
performance and achievements expressed or implied in the
forward-looking statements. These risks, uncertainties and other
factors are detailed from time to time in the company’s filings
with the Securities and Exchange Commission, including the Annual
Report on Form 10-K for the year ended December 31, 2016. The
company disclaims any intent or obligation to publicly update or
revise any forward-looking statements, regardless of whether new
information becomes available, future developments occur or
otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170731005281/en/
At IntriCon:Scott Longval, CFO,
651-604-9526slongval@intricon.comorAt Padilla:Matt Sullivan,
612-455-1700matt.sullivan@padillaco.com
Intricon (NASDAQ:IIN)
Historical Stock Chart
From Apr 2024 to May 2024
Intricon (NASDAQ:IIN)
Historical Stock Chart
From May 2023 to May 2024